Press Release

Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA — February 23, 2026 — OmicInsight, an innovator in AI-powered spatial biology and high-resolution imaging, today announced Project Cortex, a Bio-Physical AI roadmap that integrates artificial intelligence directly into laboratory hardware to automate complex biological research. Strategically headquartered in Santa Clara, California - neighboring global AI leader

Unlocking the Next Frontier of Spatial Biology with Physical AI. Meet Esper™, the integrated platform by OmicInsight that is redefining the boundaries of high-fidelity spatial analysis. By combining our gold-standard RNA FISH chemistry with proprietary Synthetic Aperture Optics (SAO), we deliver unprecedented sensitivity and resolution at a fraction of the cost. Why OmicInsight stands apart in the era of Physical AI: Autonomous Precision: Our SAO technology enables 60x oil-im

SANTA CLARA, CA and ROCKVILLE, MD — January 20, 2026 — OmicInsight Corporation, an innovator in AI-powered spatial biology and high-resolution imaging, and Psomagen, Inc., a premier North American provider of transcriptomic and genomic services, today announced a marketing agreement. Under the terms of the agreement, OmicInsight’s high-resolution imaging and multi-omics analysis capabilities, leveraging its proprietary Esper TM  platform, will be offered as a part of Psomage

SANTA CLARA, CA – January 05, 2026  – OmicInsight Corporation (hereinafter “OmicInsight”), a pioneer in AI-driven high-sensitivity spatial omics analysis, today announced a new round of strategic investment. OmicInsight has secured a new round of investment led by LOTTE Holdings (through its Healthcare & Biopharmaceutical Corporate Venture Capital), with participation from a healthcare-focused private investment firm, and existing investor Adelphi Ventures. This capital injec

Advancing collaborative research through the combination of organoid and spatial transcriptomics platforms SANTA CLARA, CA, UNITED STATES, October 29, 2025 /EINPresswire.com/ -- OmicInsight, a leader in subcellular-level, multi-omics analysis at scale, and Gradiant Bioconvergence (GBCC), a pioneer in advanced organoid platform development, today announced a strategic co-marketing agreement to jointly advance research at the interface of spatial biology and organoid science. B

Jae Won Kim joins Dr. Josh Ryu to form dual-leadership team focused on accelerating commercialization of AI-Powered Spatial Omics...